Latest Expert Opinions

Signal
Opinion
Expert
SELL
SELL
October 23, 2007
The future isn't bright. Losing market share with their main product. Suggests tax loss selling.
Novelion (NVLN-T)
October 23, 2007
The future isn't bright. Losing market share with their main product. Suggests tax loss selling.
David Baskin
President, Baskin Wealth Management
Price
$4.350
Owned
No
BUY
BUY
October 23, 2007
Some strength in the US chemical industry. Unbelievable level of profitability there. Not a bad buy. (Wait and see the earnings.)
Exxon Mobil (XOM-N)
October 23, 2007
Some strength in the US chemical industry. Unbelievable level of profitability there. Not a bad buy. (Wait and see the earnings.)
David Baskin
President, Baskin Wealth Management
Price
$92.130
Owned
Unknown
BUY
BUY
October 23, 2007
Bullish on the railways in general. CNR had a bit soggy earnings. (Due to the forestry sector). The rails have an increasing advantage over the highway trucking sector, because they are more efficient.
Bullish on the railways in general. CNR had a bit soggy earnings. (Due to the forestry sector). The rails have an increasing advantage over the highway trucking sector, because they are more efficient.
David Baskin
President, Baskin Wealth Management
Price
$51.390
Owned
Unknown
BUY
BUY
October 23, 2007
Likes cp over CN because of their product mix, and the acquisition they made in the mid-west of the US is going to turn out to be very smart over the long haul.
Likes cp over CN because of their product mix, and the acquisition they made in the mid-west of the US is going to turn out to be very smart over the long haul.
David Baskin
President, Baskin Wealth Management
Price
$67.450
Owned
Yes
BUY
BUY
October 23, 2007
A bank with a global franchise, that has been beaten up this year. You can't go too wrong. The dividend is over 5%, you're buying a world leader at 10 times earnings. There might be some short term pain, but historically banks haven't gone below 8 times earnings, so you have some protection.
CitiGroup (C-N)
October 23, 2007
A bank with a global franchise, that has been beaten up this year. You can't go too wrong. The dividend is over 5%, you're buying a world leader at 10 times earnings. There might be some short term pain, but historically banks haven't gone below 8 times earnings, so you have some protection.
David Baskin
President, Baskin Wealth Management
Price
$41.820
Owned
Unknown
DON'T BUY
DON'T BUY
October 23, 2007
Has taken it's licks. If they prevail on their lawsuits on their patents then they will go up. He likes the generics more then the big R & D houses.
Pfizer Inc (PFE-N)
October 23, 2007
Has taken it's licks. If they prevail on their lawsuits on their patents then they will go up. He likes the generics more then the big R & D houses.
David Baskin
President, Baskin Wealth Management
Price
$23.980
Owned
Unknown
BUY
BUY
October 23, 2007
Deals in rare earths and zircomium. Has a market cap of 1/2 a billion. Trading at 15 times earnings. Not a big cap or well established. Don't use the rainy day money, but worth it for a "flyer".
Deals in rare earths and zircomium. Has a market cap of 1/2 a billion. Trading at 15 times earnings. Not a big cap or well established. Don't use the rainy day money, but worth it for a "flyer".
David Baskin
President, Baskin Wealth Management
Price
$5.020
Owned
Unknown